<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ulster Med J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ulster Med J</journal-id>
      <journal-id journal-id-type="publisher-id">umj</journal-id>
      <journal-title-group>
        <journal-title>The Ulster Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0041-6193</issn>
      <publisher>
        <publisher-name>The Ulster Medical Society</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24757274</article-id>
      <article-id pub-id-type="pmc">3992099</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A potential diagnostic role of dual-phase 18F-FDG PET/CT scanning</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>Clare</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Badger</surname>
            <given-names>Stephen</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lynch</surname>
            <given-names>Tom</given-names>
          </name>
        </contrib>
        <aff>Department of Radiology, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><bold>Corresponding author</bold> Miss C Jones, Surgical Registrar, Tel: 028 90263494, Fax: 028 90263951, Email: <email>cjones82@hotmail.co.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2014</year>
      </pub-date>
      <volume>83</volume>
      <issue>1</issue>
      <fpage>52</fpage>
      <lpage>54</lpage>
      <permissions>
        <copyright-statement>&#xA9; The Ulster Medical Society, 2014</copyright-statement>
        <copyright-year>2014</copyright-year>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Editor</p>
    <p>Differentiation between benign and malignant processes is helped by positron emission tomography &#x2013; computed tomography (PET-CT). This involves a scan one hour after intravenous injection of Fluorodeoxyglucose (FDG) tracer.<xref rid="b1" ref-type="bibr">1</xref> Malignant lesions use glucose preferentially, with prolonged affinity for FDG, thus appearing as a &#x201C;hot spot&#x201D; as quantified by elevated maximum standarised uptake value (SUVmax). Infective processes also induce increased FDG uptake.<xref rid="b2" ref-type="bibr">2</xref> Dualphase scanning, which employs both early and delayed scans may separate these conditions. We report two cases where dual-phase scanning resulted in a change in the patients' diagnosis and management.</p>
    <sec>
      <title>CASES</title>
      <p>A 55-year-old male life-long smoker presented with chest pain, shortness of breath and haemoptysis. A CT scan demonstrated an obstructing lesion in the left lower lobe bronchus and distal consolidation. Bronchoscopic biopsies were reported as squamous cell carcinoma. A <sup>18</sup>F-FDG PET/CT half-body one-hour and four-hour washout studies were performed (<xref ref-type="fig" rid="fig01">Figure 1</xref>). An abnormality in the proximal left main bronchus had a SUVmax value of 13.9, with distal atelectasis and central necrosis. However, FDG uptake was seen anterolaterally within the collapsed segment, with a SUVmax of 10. Delayed imaging showed a 20% increased SUVmax of the central hilar and anterolateral peripheral lesions, with the necrotic area showing no change in SUVmax (<xref ref-type="fig" rid="fig02">Figure 2</xref>). The findings were inkeeping with hilar and peripheral malignant lesions, with surrounding inflammation. Histopathology confirmed a pT4 N1 squamous cell carcinoma, with satellite lesions and aspergillus infection in the collapsed lower lobe. Unfortunately, he developed local recurrence and bony metastases and died seven months following resection.</p>
      <fig id="fig01" position="float">
        <label>Fig 1</label>
        <caption>
          <p>The initial study demonstrating a bronchial lesion.</p>
        </caption>
        <graphic xlink:href="umj0083-0052-f1"/>
      </fig>
      <fig id="fig02" position="float">
        <label>Fig 2</label>
        <caption>
          <p>The delayed study at fours hours.</p>
        </caption>
        <graphic xlink:href="umj0083-0052-f2"/>
      </fig>
      <p>A 46-year-old female smoker presented with shortness of breath and a productive cough. CT demonstrated right upper lobe collapse and a central lesion. Bronchoscopy visualised a friable necrotic lesion obstructing the right upper lobe provisionally diagnosed as malignancy. Cytology was atypical, with a small piece of vegetable matter, suggesting aspiration. <sup>18</sup>F-FDG PET/CT showed a lesion, with a SUVmax of 5.6, in the right upper lobe bronchus, suggesting a hilar tumour and distal atelectasis with SUVmax of 4.8 (<xref ref-type="fig" rid="fig03">Figure 3</xref>). A washout study revealed a decreased SUVmax from 5.6 to 3.4 in the hilar lesion, inkeeping with inflammation (<xref ref-type="fig" rid="fig04">Figure 4</xref>). Repeat bronchoscopy retrieved vegetable matter with no histological malignancy.</p>
      <fig id="fig03" position="float">
        <label>Fig 3</label>
        <caption>
          <p>The MIP image demonstrating a bronchial lesion.</p>
        </caption>
        <graphic xlink:href="umj0083-0052-f3"/>
      </fig>
      <fig id="fig04" position="float">
        <label>Fig 4</label>
        <caption>
          <p>The delayed scan at 4 hours.</p>
        </caption>
        <graphic xlink:href="umj0083-0052-f4"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Malignant cells have upregulated GLUT transporter and hexokinase activity, trapping FDG.<xref rid="b1" ref-type="bibr">1</xref>, <xref rid="b3" ref-type="bibr">3</xref> After phosphorylation by hexokinase, FDG-6-phosphate cannot be used nor stored.<xref rid="b1" ref-type="bibr">1</xref>, <xref rid="b3" ref-type="bibr">3</xref> FDG uptake in malignant cells continues and SUVmax peaks 130-500 minutes after FDG injection.<xref rid="b4" ref-type="bibr">4</xref> Inflamed tissue, with higher metabolic rate will also light up. However, FDG will be metabolised and replaced by unlabelled glucose. If a malignant cell is present, the continued FDG uptake between scans results in higher intensity of retained FDG at 4 hours. Inflammatory cells, which retain normal glucose-6-phosphatase activity, will have decreased signal. In our experience, a rise in SUVmean of 30% correlates with malignant disease, with no increase suggesting benign diagnosis.<xref rid="b5" ref-type="bibr">5</xref> In the presence of infection satellite lesions may be missed, thus understaging the disease, with possible unnecessary non-curative surgery. Despite additional cost, a washout study can alter the management strategy of patients.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors have no conflict of interest.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Badger</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Role of PET-CT in the management of colorectal metastatic disease</article-title>
          <source>Oncol News.</source>
          <year>1934</year>
          <volume>5</volume>
          <issue>1</issue>
          <comment>17-19. Available online from: <ext-link ext-link-type="uri" xlink:href="http://www.oncologynews.biz/pdf/mar_apr_10/ONMA10_imaging.pdf">http://www.oncologynews.biz/pdf/mar_apr_10/ONMA10_imaging.pdf</ext-link>. Last accessed December 2013.</comment>
        </element-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deichen</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Prante</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gack</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schmiedehausen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kuwert</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro</article-title>
          <source>Eur J Nucl Med Mol Imaging.</source>
          <year>1934</year>
          <volume>30</volume>
          <issue>2</issue>
          <fpage>267</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">12552345</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>YX</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>QY</given-names>
            </name>
          </person-group>
          <article-title>Clinical applications and advances of positron emission tomography with fluorine-18-flurordeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms</article-title>
          <source>Postgrad Med J.</source>
          <year>1934</year>
          <volume>84</volume>
          <issue>991</issue>
          <fpage>246</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">18508981</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhuang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pourdehnad</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lambright</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Lanuti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes</article-title>
          <source>J Nucl Med.</source>
          <year>1934</year>
          <volume>42</volume>
          <issue>9</issue>
          <fpage>1412</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">11535734</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shinya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Raj</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Okumura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fujiwara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsuo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yonei</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer</article-title>
          <source>Clin Nucl Med.</source>
          <year>1934</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>216</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">19300050</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
